Using DREAM, we could show that a BSEP mutation identified in a patient with progressive familial intrahepatic cholestasis type 2 results in a trafficking defect of the mutant protein that prevents BSEP from being correctly incorporated into the plasma membrane. This evidence concerns the gene ABCB11 and progressive familial intrahepatic cholestasis type 2.